Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,437 | 13,040 | 13,720 | 13,410 | 647 |
| Marketable Securities | 10,213 | 8,400 | 7,880 | 3,350 | N/A |
| Receivables | 1,635 | 1,900 | 590 | 420 | 82 |
| Other current assets | 556 | 310 | 210 | 210 | 53 |
| TOTAL | $26,840 | $23,650 | $22,400 | $17,390 | $782 |
| Non-Current Assets | |||||
| PPE Net | 1,045 | N/A | N/A | N/A | 1,747 |
| Investments And Advances | 0 | 1,530 | 2,030 | 5,930 | 0 |
| Other Non-Current Assets | 0 | 30 | 30 | 30 | 0 |
| TOTAL | $1,045 | $1,560 | $2,060 | $5,960 | $1,747 |
| Total Assets | $27,900 | $26,100 | $25,180 | $24,000 | $1,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 920 | 810 | 710 | 0 |
| Other current liabilities | N/A | 0 | 70 | 0 | N/A |
| TOTAL | $1,703 | $1,020 | $920 | $820 | $1,891 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $140 | $120 | $120 | $N/A |
| Total Liabilities | $1,703 | $1,170 | $1,050 | $950 | $2,048 |
| Shareholders' Equity | |||||
| Common Shares | 12 | 10 | 10 | 10 | N/A |
| Retained earnings | N/A | -17,490 | -18,080 | -18,820 | N/A |
| Other shareholders' equity | 26,067 | -1,250 | -1,440 | -1,610 | -385 |
| TOTAL | $26,079 | $24,930 | $24,130 | $23,050 | $-385 |
| Total Liabilities And Equity | $27,782 | $26,100 | $25,180 | $24,000 | $1,663 |